IMDX
NASDAQ · Biotechnology
Insight Molecular Diagnostic
$5.29
+0.19 (+3.73%)
Open$5.03
Previous Close$5.10
Day High$5.45
Day Low$4.90
52W High$8.51
52W Low$2.33
Volume—
Avg Volume586.4K
Market Cap199.56M
P/E Ratio—
EPS$-1.62
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+229.1% upside
Current
$5.29
$5.29
Target
$17.41
$17.41
$14.05
$17.41 avg
$26.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.02M | 3.11M | 22.03M |
| Net Income | -62,165,301 | -34,611,055 | 4.29M |
| Profit Margin | -1,238.5% | -1,176.6% | 19.5% |
| EBITDA | -59,011,579 | -34,680,482 | 9.08M |
| Free Cash Flow | — | — | 3.08M |
| Rev Growth | +61.7% | +61.7% | +9.7% |
| Debt/Equity | — | — | 1.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |